Quantcast

Latest Sildenafil Stories

2010-10-01 13:59:27

Feature: Merging of marketing and medical science: female sexual dysfunction Drug companies have not only sponsored the science of a new condition known as female sexual dysfunction, they have helped to construct it, in order to build global markets for new drugs, reveals an article in this week's BMJ. Researching his new book 'Sex, Lies and Pharmaceuticals' Ray Moynihan, journalist and lecturer at the University of Newcastle in Australia, discovered that drug industry employees have worked...

2010-08-25 14:17:00

Product marketed for sexual enhancement is contaminated with potentially dangerous ingredient SILVER SPRING, Md., Aug. 25 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning consumers not to take TimeOut Capsules because it contains an active drug ingredient that can dangerously lower blood pressure. The product is marketed as a dietary supplement for sexual enhancement. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) (Logo:...

2010-08-17 06:30:00

CRANBURY, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced positive results of a Phase 1 clinical trial of subcutaneously administered bremelanotide, its melanocortin agonist drug candidate for treatment of male erectile dysfunction (ED) and female sexual dysfunction (FSD). The results demonstrate that with subcutaneous administration consistent therapeutic blood plasma levels can be obtained without sustained clinically significant blood...

14efbeccd66a261bb314232f41a3d93b1
2010-08-06 12:00:13

The Milwaukee Teachers' Education Association (MTEA) union is asking a judge to force the region's school board to reinstate Viagra and other erectile dysfunction drugs to their taxpayer-funded health care coverage, according to a Friday report by Associated Press (AP) writer Ryan J. Foley. According to Foley, "The filing is the latest in a two-year legal campaign in which the union has argued, so far unsuccessfully, that the board's policy of excluding erectile dysfunction drugs...

2010-06-24 06:30:00

CRANBURY, N.J., June 24 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced the completion of patient dosing and database lock in a double-blind, placebo-controlled, multiple dose, crossover study of bremelanotide, its subcutaneously administered melanocortin agonist for treatment of erectile dysfunction (ED). Palatin expects to report top-line data in the next calendar quarter. The endpoints in the study are evaluation of plasma exposure and blood...

2010-06-19 16:40:00

Product marketed as sexual enhancement is contaminated with potentially dangerous ingredient SILVER SPRING, Md., June 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration is warning consumers that Magic Power Coffee, an instant coffee product marketed as a dietary supplement for sexual enhancement, contains an active drug ingredient that can dangerously lower blood pressure. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:...

fb905fc98aa63cd7e7d7349aa679b00b1
2010-06-17 06:35:00

The drug industry's latest attempt to find a female equivalent to Viagra fell short in two separate studies, according to federal regulators on Wednesday. The Food and Drug Administration is considering Boehringer Ingelheim's drug flibanserin for pre-menopausal women who experienced a lack in sexual desire, a market that drug makers have been targeting for years since the epic success of Viagra for men. The hunt for a female version of Viagra has proved elusive though, with many drugs...

48b2af09c97e026a7aa9d5e7d9eca0741
2010-06-10 14:45:00

The FDA annoucned that it has warned Pfizer Inc for failing to quickly report serious and unexpected potential side effects from its drugs that have already been placed on the market. The FDA wrote a 12-page warning letter to Pfizer Chief Executive Jeffery Kinder that cited numerous examples involving some of the company's top-known brands, including impotence drug Viagra, cholesterol pill Lipitor and seizure medicine Lyrica. According to the FDA's letter that was released by Pfizer on...

2010-06-09 08:00:00

WALTHAM, Mass., June 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that while United Therapeutics' Tyvaso and Adcirca--launched in 2009--are each prescribed by more than half of surveyed pulmonologists in the specialized pulmonary arterial hypertension (PAH) center setting, Adcirca is much more widely used than Tyvaso among surveyed non-PAH-center physicians. The new Physician & Payer Forum...

f71b917e3e389ca467d7fb98f69cf3d61
2010-05-18 11:36:35

Research by a University of Alabama at Birmingham (UAB)  professor shows an association between hearing loss and the use of the erectile dysfunction drug Viagra. Findings published May 18 in Archives of Otolaryngology-Head and Neck Surgery indicate a potential for long-term hearing loss following use of Viagra, and possibly following use of other phosphodiesterase type 5 inhibitors (PDE-5i) drugs such as Cialis and Levitra, although results on those drugs are inconclusive. "It appears...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related